DNMT3A and cancer: In laboratory settings, DNC has been shown to reactivate the expression of miR-34s by inhibiting DNMT1, DNMT3A, and DNMT3B in HepG2 and Huh7 cell lines, reducing the viability of these cancer cells [56].